Duygu Alptekin Gürsu
AUTHOR

Duygu Alptekin Gürsu

Tap the gear icon above to manage new release emails.
Duygu Alptekin Gürsu is an internationally acclaimed, award-winning leadership and team coach and keynote speaker who brings a wealth of experience from her exceptional 29 year career as a woman business leader and executive coach. She holds the esteemed Master Certified Coach (MCC) credential and is among the first to earn the Advanced Certified Team Coach (ACTC) designation from the International Coach Federation. She is dedicated to unlocking the full potential of top and mid-level executives, high-potential individuals, and executive management teams in global corporations. With a successful international business background, extensive multi-cultural coaching experience, and organizational positive psychology acumen, Duygu converts her deep understanding of the corporate landscape into both a challenging and supportive space for her clients. She has coached executives in over fifty countries, and her blue-chip clients include Nestle, Loreal, Johnson & Johnson, Mayo Clinic, Microsoft, Roche, Workday, Service Now, Equinix, Philips, Pfizer, Novartis, Unilever, Coca-Cola, GlaxoSmithKline, Vodafone, and Volvo. She is married with one son and resides with her family in Istanbul, Türkiye. She is also the author of the international best-selling book Transformational Leadership: Inspire the Excellence Within, published first in 2023.
Read more Read less

Best Sellers

Product List
  • Transformational Leadership cover art

    • Transformational Leadership

    • Inspire the Excellence Within: A Guide and Workbook with Proven Strategies and Real-Life Stories to Unleash Your Leadership Potential
    • Written by: Duygu Alptekin Gürsu
    • Narrated by: MaryJane Baer
    • Length: 6 hrs and 45 mins
    • Release Date: 13-05-25
    • Language: English
    • Not rated yet

    Regular price: ₹374.00

    Free with 30-day trial
  • Empowering Women on the Way to the Top cover art

    Regular price: ₹374.00

    Free with 30-day trial